150 related articles for article (PubMed ID: 36856760)
21. CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
[TBL] [Abstract][Full Text] [Related]
22. Morular metaplasia misdiagnosed as adenoacanthoma in young women with polycystic ovarian disease.
Blaustein A
Am J Surg Pathol; 1982 Apr; 6(3):223-8. PubMed ID: 7102901
[TBL] [Abstract][Full Text] [Related]
23. Synchronous ovarian and uterine mesonephric-like carcinoma that potentially arose from endometrioid adenofibroma: A case report.
Ishida K; Ashihara T; So M; Minamiguchi S; Matsumura N; Nonogaki T
J Obstet Gynaecol Res; 2023 Mar; 49(3):1052-1056. PubMed ID: 36597276
[TBL] [Abstract][Full Text] [Related]
24. Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma.
Patel V; Kipp B; Schoolmeester JK
Hum Pathol; 2019 Apr; 86():243-248. PubMed ID: 30172914
[TBL] [Abstract][Full Text] [Related]
25. Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.
Ma T; Chai M; Shou H; Ru G; Zhao M
Front Oncol; 2022; 12():911695. PubMed ID: 35865471
[TBL] [Abstract][Full Text] [Related]
26. Morules and morule-like features associated with carcinomas in various organs: report with immunohistochemical and molecular studies.
Makishi S; Kinjo T; Sawada S; Chinen K; Hirayasu T; Hamada T; Saito K; Iwamasa T
J Clin Pathol; 2006 Jan; 59(1):95-100. PubMed ID: 16394288
[TBL] [Abstract][Full Text] [Related]
27. Shadow cell differentiation from squamoid morule in endometrial adenoacanthoma.
Nakamura T
Int J Clin Exp Pathol; 2015; 8(10):13120-4. PubMed ID: 26722510
[TBL] [Abstract][Full Text] [Related]
28. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases].
Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616
[No Abstract] [Full Text] [Related]
29. Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
Choi KH; Kim H; Bae GE; Lee SH; Woo HY; Kim HS
Anticancer Res; 2021 Sep; 41(9):4587-4601. PubMed ID: 34475087
[TBL] [Abstract][Full Text] [Related]
30. Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation.
Skala SL; Gregg PA; Orr JW; Udager AM; Brown NA; Cho KR
Int J Gynecol Pathol; 2020 Sep; 39(5):452-455. PubMed ID: 31335448
[TBL] [Abstract][Full Text] [Related]
31. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.
Byron SA; Gartside M; Powell MA; Wellens CL; Gao F; Mutch DG; Goodfellow PJ; Pollock PM
PLoS One; 2012; 7(2):e30801. PubMed ID: 22383975
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary metastasis of cribriform-morular variant of thyroid carcinoma mimicking primary adenocarcinoma of the lung: A potential pitfall.
Laforga JB; Pedro T; Gasent JM
Diagn Cytopathol; 2020 Jan; 48(1):78-81. PubMed ID: 31483569
[TBL] [Abstract][Full Text] [Related]
33. [Proliferative lesions with mesonephric features in the gynecologic tract: a clinicopathological analysis of sixteen cases].
Mo N; He CY; Yu HY; Bian XT; Jin YL
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1000-1006. PubMed ID: 36207913
[No Abstract] [Full Text] [Related]
34. Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
Mirkovic J; Olkhov-Mitsel E; Amemiya Y; Al-Hussaini M; Nofech-Mozes S; Djordjevic B; Kupets R; Seth A; McCluggage WG
Histopathology; 2023 Jun; 82(7):978-990. PubMed ID: 36860193
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract][Full Text] [Related]
36. Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma.
Chibbar R; Foerstner S; Suresh J; Chibbar R; Piche A; Kundapur D; Kanthan R; Kundapur V; Lee CH; Agrawal A; Lai R
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):181-188. PubMed ID: 36695555
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of morules in colonic neoplasms: morules are morphologically and qualitatively different from squamous metaplasia.
Ueo T; Kashima K; Daa T; Kondo Y; Sasaki A; Yokoyama S
Pathobiology; 2005; 72(5):269-78. PubMed ID: 16374071
[TBL] [Abstract][Full Text] [Related]
38. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
39. Aberrant intranuclear localization of biotin, biotin-binding enzymes, and beta-catenin in pregnancy-related endometrium and morule-associated neoplastic lesions.
Gamachi A; Kashima K; Daa T; Nakatani Y; Tsujimoto M; Yokoyama S
Mod Pathol; 2003 Nov; 16(11):1124-31. PubMed ID: 14614052
[TBL] [Abstract][Full Text] [Related]
40. Colonic invasive adenocarcinoma with squamoid morules: A case report.
Ishikawa A; Tanaka H; Yamashita K; Arihiro K; Oka S; Shimomura M; Ohdan H
DEN Open; 2024 Apr; 4(1):e330. PubMed ID: 38264462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
